ChemImage & Ethicon Partner to Progress the Development of Advanced Visualization Tools in Surgery

An innovative collaboration between experts in molecular chemical imaging and surgery that aims to re-shape the future of surgery


PITTSBURGH, Pennsylvania, March 31, 2020 ChemImage is a Pittsburgh-based molecular chemical imaging company working to solve important unmet needs in healthcare with breakthrough technology. ChemImage has entered into a partnership with Ethicon, Inc., a medical device company of the Johnson & Johnson family of companies, to progress the development of ChemImage’s proprietary visualization and Awareness of ThingsTM (AoTTM) Platform for healthcare applications. ChemImage technology can provide clinicians with critical information and situational awareness about the in-vivo environment, with the goal of improving both efficiency of care and patient outcomes. “We are excited to enter into this agreement to bring advanced intraoperative visualization to surgeons to help improve surgical accuracy and safety for patients around the world,” stated Jeffrey Cohen, MD, President of ChemImage. “We are looking forward to a long and successful relationship.”

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.